India  

Lancet publishes Covaxin phase 2 trials data

IndiaTimes Tuesday, 9 March 2021
prestigious medical journal The Lancet has now published Phase 2 clinical trial results of Bharat Biotech's Covaxin. "Due to the difference in dosing regimens between Phase 1 (two doses given 2 weeks apart) and phase 2 (two doses given 4 weeks apart) trials, neutralisation responses were significantly higher in the phase 2 trial than in the phase 1 trial, said the research paper published in Lancet."
0
shares
ShareTweetSavePostSend
 

💡 newsR Knowledge: Other News Mentions

BBV152 BBV152 Vaccine against COVID-19

Use entire national capacity to step up Covid vaccine production, PM tells officials

The PM’s directive came at a review meeting on the Covid situation on Saturday a day after he had overseen an assessment of oxygen supplies and production and..
IndiaTimes

Covaxin production to be increased to 100 million doses per month by September 2021: Centre

Union health minister Harsh Vardhan said financial support is being provided to four manufacturers to expand Covaxin vaccine production.
DNA

India to increase Covaxin production to 100 million doses per month by September

The Union government on Friday said it will amp up the production of the indigenously developed Covaxin vaccine to 100 million doses per month by September. As..
IndiaTimes
Mumbai's Haffkine Institute gets Centre's nod to produce Covaxin [Video]

Mumbai's Haffkine Institute gets Centre's nod to produce Covaxin

The Central Government has given permission to Haffkine Institute to produce Bharat Biotech's Covaxin. CM Uddhav Thackeray thanked PM Modi through a tweet by CM office, Maharashtra on April 15, "The Dept of Science and Technology, Government of India, has granted approval to Haffkine Institute to produce Bharat Biotech's Covaxin vaccine on a transfer of technology basis. CM Uddhav Balasaheb Thackeray has thanked the Hon'ble PM Shri@narendramodi for approving this request."

Credit: ANI    Duration: 01:14Published

Bharat Biotech Bharat Biotech Indian biotechnology company and vaccine manufacturer

Even as Covid vaccine demand rises, firms may take some weeks to up production

Indications are that India’s vaccine production is expected to be limited for a few more weeks though a step-up is expected as Serum Institute of India and..
IndiaTimes

You Might Like


Related videos from verified sources

Voting begins for fourth phase of West Bengal Assembly polls [Video]

Voting begins for fourth phase of West Bengal Assembly polls

Polling began at 7 am on April 10 for the fourth phase of West Bengal Assembly elections. People queued up at a polling station in Domjur Assembly constituency in Howrah to exercise their franchise...

Credit: ANI     Duration: 01:51Published
Phase 3 Clinical Trial Of Pfizer Covid-19 Vaccine Remains Highly Effective After Six Months [Video]

Phase 3 Clinical Trial Of Pfizer Covid-19 Vaccine Remains Highly Effective After Six Months

CBS4's Hank Tester reports on how Pfizer confirmed this week that an ongoing Phase 3 clinical trial of its coronavirus vaccine remains highly effective for at least six months after the second dose.

Credit: CBS4 Miami     Duration: 02:26Published
West Bengal, Assam vote in second phase of assembly polls: All you need to know [Video]

West Bengal, Assam vote in second phase of assembly polls: All you need to know

Polling began at 7 am for 30 seats in the second phase of West Bengal assembly elections. Voters queue outside polling stations to cast their votes amid tight security. The second phase also includes..

Credit: HT Digital Content     Duration: 03:29Published

Related news from verified sources

Parliament passes bill to raise upper limit for abortions to 24 weeks in special cases

Rajya Sabha on Tuesday passed a bill to raise the upper limit for permitting abortions from the present 20 weeks to 24 weeks for "special categories of women"...
IndiaTimes Also reported by •Indian Express

Govt raises gap between Covishield shots to 4-8 weeks

The health ministry on Monday revised the interval between two doses of the Covishield vaccine to 4-8 weeks, from the existing 4-6 weeks, after evidence showed...
IndiaTimes Also reported by •Mid-Day

Mumbai: 50 per cent BEST employees vaccinated for COVID-19 in 2 weeks

Mumbai: 50 per cent BEST employees vaccinated for COVID-19 in 2 weeks
“Over 16,000 have already received the vaccine in the past two weeks, and the process for the rest is under process,” said Dr Anil Kumar Singal,...
Mid-Day